Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Memorial Sloan Kettering Cancer Center
A

2020 Updates on Stage 4 Melanoma: Do BRAF+ MEK Combos Improve PFS? Is Nivo+Ipi More Beneficial for PFS/OS vs. Nivo/Ipi Mono? What About Cobimetinib+Vemurafenib+Atezo Triplet Therapy?

By Memorial Sloan Kettering Cancer Center FEATURING Allison Betof Warner
By Memorial Sloan Kettering Cancer Center FEATURING Allison Betof Warner
296 views
November 27, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
Skin
29:16
Insights from 2023 IGCS Annual Meeting

IGCS 2023 Insights: "Vulvovaginal Melanoma - Current Approaches…

Feat. M. Leitao
24:53
OncoAlert

Recent Melanoma Updates

Feat. A. Betof Warner
04:04
GRACE

Clinical Trials in Melanoma

Feat. M. Postow
02:49
GRACE

Major Advances in Uveal Melanoma

Feat. M. Postow
04:28
GRACE

BRAF Mutated Melanoma

Feat. M. Postow
03:10
GRACE

Side Effects of Immunotherapy in Melanoma

Feat. M. Postow
08:00
GRACE

Immunotherapy in Treatment of Melanoma

Feat. M. Postow
05:50
GRACE

Melanoma and Current Treatment Options

Feat. M. Postow
11:42
Memorial Sloan Kettering Cancer Center

Who Should Be Getting Adjuvant Therapy in Melanoma?

Feat. A. Betof Warner
47:34
Massachusetts General Hospital Cancer Center

Confronting Inequity in Modern Therapy for Rare Melanomas

Feat. A. Shoushtari
10:11
Memorial Sloan Kettering Cancer Center

2022 Updates in the Treatment of Melanoma

Feat. M. Postow
06:32
Memorial Sloan Kettering Cancer Center

2021 ASCO Highlights on 1L Treatment for Advanced Melanoma: RELATIVI…

Feat. A. Betof Warner
15:05
Memorial Sloan Kettering Cancer Center

2020 Updates on Stage 4 Melanoma: Do BRAF+ MEK Combos Improve PFS? I…

Feat. A. Betof Warner
13:02
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Skin Toxicities are First and Frequent in Immunotherapy

Feat. M. Lacouture
14:10
Weill Cornell Medicine Courses and Meetings

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors a…

Feat. P. Chapman